Methods We included English-language published studies with cost as a focal point using a
primary data source to inform resource usage of women with breast cancer. We focussed on …

Breast and gynecologic cancers are common across the world and are associated with
substantial societal and economic burden. Pembrolizumab was among the first immune …

Previous evidence on productivity losses from neoplasms focuses mostly on the economic
burden from mortality, covers single cancer diagnoses and neglects non-malignant …

Introduction: Neoadjuvant therapy constitutes a valuable modality for diminishing tumor
volume prior to surgical resection. Nonetheless, its application encounters limitations in the …

Introduction Abemaciclib is an oral inhibitor of cyclin-dependent kinases 4 and 6 (CDK4/6).
Data from the clinical trial monarchE (2023) showed improved survival from invasive …

Objective The aim of this study is to estimate the indirect economic burden of 22 cancer
types in Jordan using both the human capital approach (HCA) and the value of a statistical …

Introduction Cancer diagnosis influences the choices that patients make regarding current
and future labor market activity. These choices have implications for governments based on …

乳腺癌是全球最常见的恶性肿瘤之一和第五大肿瘤死因, 造成了巨大经济, 社会和疾病负担,
是全球性重要卫生问题之一. 早期诊断对于乳腺癌有效治疗和良好预后至关重要 …

This study aimed to estimate the medical cost of cancer in the first five years of diagnosis
and in the final six months before death in people who developed cancer after human …

Identifying financial toxicity (FT) following a cancer diagnosis is critical for providing
interventions and support to patients. There is virtually no research on FT in patients with …